Hyper Corporation Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

1997

Location

Seoul South Korea

Primary Industry

Healthcare Specialists

About

Founded in 1997 and based in Seoul, South Korea, Hyper Corporation Inc., formerly Medifron DBT Inc., operates as a biotechnology company that develops a suite of pharmaceutical and IT-based solutions that diagnose and treat Alzheimer's disease in patients. In July 2024, FutureStream Networks acquired an undisclosed stake in Hyper Corporation Inc. Financial terms were not disclosed. The acquisition aims to support FutureStream Networks to improve its AI-based business solutions and to change the business structures of its existing tech-based companies through its synergy with Hyper Corporation Inc.

Current Investors

T.S. Investment, FutureStream Networks

Request a demo to show more

Primary Industry

Healthcare Specialists

Sub Industries

Biopharmaceuticals, Healthcare IT, Mental Health Services, Diagnostic Equipment, Medical Software

Website

www.hyper-corp.com

Verticals

HealthTech, Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Deals

Deals Type
Add-on, Public to Private
Trade Sale
Private Debt
Private Debt
Private Placement/Follow on

Deal Status	Target (s)	Deal Date
Completed	Hyper Corporation Inc.	01 Jul 2024
Completed	SJ CORE Co.,Ltd.	03 Dec 2020
Completed	Hyper Corporation Inc.	01 Sep 2020
Completed	Hyper Corporation Inc.	12 May 2020
Completed	Hyper Corporation Inc.	17 Mar 2016

Displaying 1-5 of 6

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.